# Merganser Biotech, Inc. — Form D/A

Merganser Biotech, Inc. of King of Prussia, PA, a company, filed a Form D amendment with the SEC on 2016-04-29. The offering totals $17.1M, of which $13.1M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2016-04-29
- Form: D/A
- Accession: 0001635172-16-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $17.1M
- Amount sold: $13.1M
- Remaining: $4.0M
- Investors: 24
- Date of first sale: 2015-02-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-234935

## Issuer

- Name: Merganser Biotech, Inc.
- CIK: 0001635172
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 1004 West 9th Avenue, Suite 115, King of Prussia, PA, 19406
- Phone: 484-590-5290

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Jeffrey Bird | Director | San Mateo, CA |
| Colin Goddard | Director | JUPITER, FL |
| Markus Goebel | Director | Sunnyvale, CA |
| Brian MacDonald | Director | Carlsbad, CA |
| James Topper | Director | La Jolla, CA |
| Brian MacDonald | Executive Officer | Carlsbad, CA |
| Remy Sukhija | Executive Officer | King of Prussia, PA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2015-02-27](https://search.stillhousedata.com/formd/0001635172-15-000002) | D | $27.9M | $8.0M |

## More

- [CIK 1635172 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1635172&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001635172-16-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.